ctrl K

Eton Pharmaceuticals Inc. (ETON)

NASDAQ: ETON · Real-Time Price · USD

16.95

0.10 (0.59%)

At close: May 01, 2025, 3:59 PM

17.05

0.56%

Pre-market: May 02, 2025, 06:34 AM EDT

Eton Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	39.01M	31.64M	21.25M	21.83M	39K	959K	n/a	n/a
Cost of Revenue	15.6M	10.58M	6.93M	2.62M	286K	453K	63K	13K
Gross Profit	23.41M	21.06M	14.32M	19.21M	-247K	506K	-63K	-13K
Operating Income	-2.6M	-1.19M	-8.26M	-1.5M	-27.11M	-18.6M	-10.32M	-7.15M
Interest Income	n/a	n/a	761K	1.01M	859K	281K	164K	52.5K
Pretax Income	-3.81M	-689K	-9.02M	-1.96M	-27.97M	-18.32M	-12.74M	-7.16M
Net Income	-3.82M	-936K	-9.78M	-2.96M	-28.83M	-18.04M	-12.74M	-7.16M
Selling & General & Admin	22.75M	18.93M	18.58M	14.47M	12.76M	7.55M	4.69M	3.21M
Research & Development	3.25M	3.32M	4M	6.24M	14.1M	11.55M	5.63M	3.93M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	26.01M	22.25M	22.58M	20.7M	26.86M	19.11M	10.32M	7.14M
Interest Expense	n/a	n/a	955K	1.01M	889K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.62M
Cost & Expenses	41.61M	32.83M	29.51M	23.33M	27.15M	19.56M	10.32M	7.15M
Income Tax Expense	15K	247K	761K	1.01M	859K	-281K	-2.58M	n/a
Shares Outstanding (Basic)	25.89M	25.64M	25.15M	25.21M	21.01M	17.76M	6.42M	17.46M
Shares Outstanding (Diluted)	25.89M	25.65M	25.15M	25.21M	21.01M	17.76M	6.42M	17.46M
EPS (Basic)	-0.15	-0.04	-0.39	-0.12	-1.37	-1.02	-1.99	-0.41
EPS (Diluted)	-0.15	-0.04	-0.39	-0.12	-1.37	-1.02	-1.99	-0.41
EBITDA	-1.45M	-291K	-6.49M	-1.12M	-26.46M	-18.15M	-10.26M	-7.14M
EBIT	-2.6M	-1.19M	-8.26M	-1.5M	-27.11M	-18.6M	-10.32M	-7.16M
Depreciation & Amortization	1.15M	901K	1.76M	447K	651K	447K	63K	13K